Results 221 to 230 of about 19,190 (266)

Identification of diagnostic and prognostic genetic alterations in uveal melanoma using RNA sequencing. [PDF]

Sci Rep
Nell RJ, Versluis M, Cats D, Mei H, Verdijk RM, Kroes WGM, Luyten GPM, Jager MJ, van der Velden PA.   +8 more
europepmc   +1 more source

RNA-binding proteins as therapeutic targets in cancer. [PDF]

RNA Biol
Jungfleisch J, Gebauer F.
europepmc   +1 more source

SF3B1 mutation arises at the multipotent HSC level [PDF]

Blood, 2017
openaire   +2 more sources

Editorial: MDS: new scientific and clinical developments. [PDF]

Front Oncol
Blum S, Symeonidis A, Germing U.
europepmc   +1 more source

Genome sequencing in the management of myelodysplastic syndromes and related disorders. [PDF]

Haematologica
Cazzola M, Malcovati L.
europepmc   +1 more source

Complex Genetic Evolution and Treatment Challenges in Myeloid Neoplasms: A Case of Persistent t(2;3)(p15~23;q26)/MECOM Rearrangement, SF3B1 Mutation, and Transient TNIP1::PDGFRB Chimera. [PDF]

Cancer Genomics Proteomics
Andersen K, Tjønnfjord GE, Hestdalen ML, Spetalen S, Panagopoulos I.   +4 more
europepmc   +1 more source

Clonal Hematopoiesis: Impact on Health and Disease. [PDF]

Hematol Oncol
Caiado F, Manz MG.
europepmc   +1 more source

Venetoclax and azacitidine compared with intensive chemotherapy for adverse-risk acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation in first complete remission: A multicenter study of TROPHY group. [PDF]

Chin J Cancer Res
Wen Q, Jiang C, Liu X, Xia Y, Ma Y, Yang Y, Wang Y, Chang Y, Wang L, Zhang Z, Huang X, Cao Y, Zhao Y, Hu X, Mo X.   +14 more
europepmc   +1 more source

ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker. [PDF]

Leukemia
Thorvaldsdottir B, Mansouri L, Sutton LA, Nadeu F, Meggendorfer M, Parker H, Brieghel C, Laidou S, Moia R, Rossi D, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfò L, Mattsson M, Davis Z, Baliakas P, Rapado I, Miras F, Martinez-Lopez J, de la Serna J, Hernández Rivas JM, Larráyoz MJ, Calasanz MJ, Smedby KE, Espinet B, Puiggros A, Bullinger L, Bosch F, Tazón-Vega B, Baran-Marszak F, Oscier D, Nguyen-Khac F, Zenz T, Terol MJ, Cuneo A, Hernández-Sánchez M, Pospisilova S, Gaidano G, Niemann CU, Campo E, Strefford JC, Ghia P, Stamatopoulos K, Rosenquist R.   +47 more
europepmc   +1 more source

Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances. [PDF]

Cancers (Basel)
Thalambedu N, Mohan Lal B, Harbaugh B, Alapat DV, Gaddam M, Gentille Sanchez CG, Kumaran M, Varma A.   +7 more
europepmc   +1 more source